Premium
Low prevalence of human T cell lymphotropic virus type 1 infection in patients with gastric cancer
Author(s) -
Hirata Tetsuo,
Nakamoto Manabu,
Nakamura Masamoto,
Kinjo Nagisa,
Hokama Akira,
Kinjo Fukunori,
Fujita Jiro
Publication year - 2007
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1111/j.1440-1746.2006.04740.x
Subject(s) - medicine , cancer , odds ratio , incidence (geometry) , gastroenterology , logistic regression , colorectal cancer , immunology , physics , optics
Background and Aim: There have been few studies on the association between human T cell lymphotropic virus type 1 (HTLV‐1) infection and cancer risk. It is still controversial whether or not HTLV‐1 infection affects the incidence of several cancers. With this background, we aimed to evaluate the relationship between HTLV‐1 infection and the occurrence of several types of cancers. Methods: Subjects were 699 patients with cancer aged 50 years and older diagnosed between 1991 and 2004 at the Department of Medicine and Therapeutics, Ryukyu University Hospital, Okinawa, Japan, and 1365 control patients without cancer. The association between HTLV‐1 infection and cancer (biliary tract, pancreatic, esophageal, gastric, colorectal, liver, and lung cancers) was analyzed by logistic regression analysis adjusted for age and sex. Results: The infection rate of HTLV‐1 in patients with gastric cancer was significantly lower than in controls ( P = 0.01, adjusted odds ratio 0.46). The infection rate of HTLV‐1 was not associated with increased or decreased risk of cancers other than gastric cancer. Conclusion: Our study indicated that the prevalence of HTLV‐1 infection in patients with gastric cancer appears to be significantly lower than that in control patients.